FREE Account Opening + No Clearing Fees
Loading...

Emcure Pharma IPO vs Sanstar IPO

Comparision between Emcure Pharma IPO and Sanstar IPO.

IPO Details

Emcure Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Sanstar IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

  Emcure Pharma IPO Sanstar IPO
Logo Emcure Pharma IPO Logo Sanstar IPO Logo
Issue Category Mainline Mainline
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At BSE, NSE BSE, NSE
Lead Managers Kotak Mahindra Capital Company Limited

Axis Capital Limited

J.P. Morgan India Private Limited

Jefferies India Private Limited
Pantomath Capital Advisors Pvt Ltd
Registrar Link Intime India Private Ltd Link Intime India Private Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor Anchor Investor Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Emcure Pharma IPO is up to ₹1,952.03 Cr whereas the issue size of the Sanstar IPO is up to ₹510.15 Cr. The final issue price of Emcure Pharma IPO is ₹1,008.00 per share and of Sanstar IPO is ₹95.00 per share.

  Emcure Pharma IPO Sanstar IPO
Face Value ₹10 per share ₹2 per share
Issue Price (Lower) ₹960.00 per share ₹90.00 per share
Issue Price (Upper) ₹1,008.00 per share ₹95.00 per share
Issue Price (Final) ₹1,008.00 per share ₹95.00 per share
Discount (Retail)
Discount (Employee) ₹90.00 per share
Market Lot Size 14 shares 150 shares
Fresh Issue Size 79,36,507 shares 4,18,00,000 shares
Fresh Issue Size (Amount) up to ₹800.00 Cr up to ₹397.10 Cr
OFS Issue Size 1,14,28,839 shares 1,19,00,000 shares
OFS Issue Size (Amount) up to ₹1,152.03 Cr up to ₹113.05 Cr
Issue Size Total 1,93,65,346 shares 5,37,00,000 shares
Issue Size Total (Amount) up to ₹1,952.03 Cr up to ₹510.15 Cr

IPO Timetable

Emcure Pharma IPO opens on Jul 03, 2024, while Sanstar IPO opens on Jul 19, 2024. The closing date of Emcure Pharma IPO and Sanstar IPO is Jul 05, 2024, and Jul 23, 2024, respectively.

  Emcure Pharma IPO Sanstar IPO
Anchor Bid Date Jul 02, 2024 Jul 18, 2024
Issue Open Jul 03, 2024 Jul 19, 2024
Issue Close Jul 05, 2024 Jul 23, 2024
Basis Of Allotment (Tentative) Jul 08, 2024 Jul 24, 2024
Initiation of Refunds (Tentative) Jul 09, 2024 Jul 25, 2024
Credit of Share (Tentative) Jul 09, 2024 Jul 25, 2024
Listing date (Tentative) Jul 10, 2024 Jul 26, 2024
Anchor Lockin End date 1 Aug 07, 2024 Aug 23, 2024
Anchor Lockin End date 2 Oct 06, 2024 Oct 22, 2024

Financials

Emcure Pharma IPO P/E ratio is 34.55, as compared to Sanstar IPO P/E ratio of 19.98.

  Emcure Pharma IPO Sanstar IPO
Financial

Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)

Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Assets7,806.166,672.536,063.47
Revenue6,715.246,031.725,918.86
Profit After Tax527.58561.85702.56
Net Worth2,952.282,501.131,987.55
Reserves and Surplus2,722.402,293.771,791.03
Total Borrowing2,091.942,202.422,102.19
Amount in ₹ Crore

Sanstar Limited Financial Information (Restated Consolidated)

Sanstar Limited's revenue decreased by -10.58% and profit after tax (PAT) rose by 59.71% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Assets527.57368.35207.45
Revenue1,081.681,209.67504.77
Profit After Tax66.7741.8115.92
Net Worth215.91149.2848.97
Reserves and Surplus225.18158.4155.69
Total Borrowing127.64111.7085.22
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue) 98.90% 99.77%
Promoter Shareholding (Post-Issue) 78.24% 70.37%
P/E Ratio 34.55 19.98
Market Cap ₹19029.89 Cr. ₹1731.32 Cr.
ROE 16.90%% 30.92%%
ROCE 19.37%% 24.43%%
Debt/Equity 0.67 0.5
EPS ₹29.17 ₹4.75
RoNW 16.87%% 30.92%%

Shares Offered

In the Emcure Pharma IPO retail investors (RII) are offered 67,43,160 shares while in Sanstar IPO retail investors are offered 67,43,160 shares. Qualified institutional buyers (QIB) are offered 38,53,234 shares in Emcure Pharma IPO and 1,07,40,000 shares in Sanstar IPO.

  Emcure Pharma IPO Sanstar IPO
Anchor Investor Reserveration 57,79,850 shares 1,61,10,000 shares
Market Maker Reserveration
QIB 38,53,234 shares 1,07,40,000 shares
NII 28,89,926 shares 80,55,000 shares
RII 67,43,160 shares 1,87,95,000 shares
Employee 1,08,900 shares 0 shares
Others
Total 1,37,03,538 shares 3,75,90,000 shares

Bids Received (Subscription)

Emcure Pharma IPO subscribed 67.87x in total, whereas Sanstar IPO subscribed 82.99x.

  Emcure Pharma IPO Sanstar IPO
QIB (times) 191.24x 145.68x
NII (times) 49.32x 136.49x
Big NII (times) 54.90x 149.44x
Small NII (times) 38.16x 110.61x
RII (times) 7.36x 24.23x
Employee (times) 8.81x
Other (times)
Total (times) 67.87x 82.99x

Comments

Add a public comment...